Resources Contact Us Home
Modified factor VIII

Image Number 5 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Storage device, data processing device, registration method, and recording medium
Routing of data including multimedia between electronic devices
Accessory system for vehicle
Silicon-on-insulator (SOI) structure configured for reduced harmonics and method of forming the structure
Method of treating cancer using a survivin inhibitor
CMOS image sensor
  Randomly Featured Patents
Drive disk for the tool of a machine for conditioning and/or maintaining floors and machine provided with a disk of this kind
Resonant oscillating mass-based torquing tool
Synchronization control device for servo motors
Sensor device
Apparatus for supporting formwork panels in wall construction
Stage apparatus and exposure apparatus
Multiple purpose garment and accessory rack
Alloy target, its fabrication, and regeneration processes
Connection for the operating rod of a high hat stand
Slatwall extrusion